Diakonhjemmet Hospital   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Oslo Norway (1890)

Organization Overview

First Clinical Trial
2001
NCT00419146
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Diakonhjemmet | Diakonhjemmet Hospital

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthritis (Phase 4)

Arthritis, Psoriatic (Phase 4)

Arthritis, Rheumatoid (Phase 4)

Atrial Fibrillation (Phase 4)

Atrial Flutter (Phase 4)

Back Pain (Phase 3)

Colitis (Phase 4)

Colitis, Ulcerative (Phase 4)

Crohn Disease (Phase 4)

Dementia (Phase 4)

Disease (Phase 3)

Low Back Pain (Phase 3)

Mental Disorders (Phase 3)

Osteoarthritis (Phase 4)

Psoriasis (Phase 4)

Psychotic Disorders (Phase 3)

Schizophrenia (Phase 3)

Spondylarthritis (Phase 4)

Ulcer (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 9
  • # of Trial APIs: 16